Background/Objectives: Specific maternal risk factors have recently been identified
| INTRODUCTION
Previous studies seeking to describe maternal risk factors implicated in the development of infantile hemangiomas (IH) have determined that multiple gestation, female sex, low birthweight, prematurity, use of certain prenatal medications (progesterone and corticosteroids), invasive antepartum procedures, and placental abnormalities increase infant risk for IH. [1] [2] [3] [4] [5] Recently, gestational diabetes mellitus (GDM) and gestational hypertension were also identified as significant risk factors. 6 This population-based study was designed to explore the prenatal risk factors associated with IH, including trends over time, and the association with the previously reported increasing incidence of IH. The REP is a medical records linkage system allowing for access to records for nearly all patient encounters in Olmsted County, Minnesota, since the 1960s. This resource provides a means to identify all diagnosed cases of IH in a geographically defined community; the REP also links maternal medical records to infant charts. The potential for the REP database to be used in a population-based study has been previously described.
T A B L E Comparison of birth mother features by year of infantile hemangioma diagnosis

| MATERIALS AND METHODS
Institutional
7-9
Categorical features were summarized with frequency counts and percentages; continuous features were summarized with medians and interquartile ranges (IQRs). Associations of features of the birth mothers over time were evaluated using Spearman's rank correlation coefficients and Cochran-Armitage trend tests. Statistical analyses were performed using version 9.4 of the SAS software package (SAS Institute, Cary, NC). All tests were two-sided, and P-values < 0.05 were considered statistically significant. (Table 1) .
| RESULTS
Rates
Rates of ART in this population increased from < 1% to 6%
( Mean para was 1.8, 1.9, and 1.8, respectively.
medications also increased over the 35-year period. Of the maternal medications studied, prenatal progesterone use significantly increased from < 1% to 19% (P < 0.001) over the study period; corticosteroid use also significantly increased from 2% to 12% (P < 0.001). Placental abnormalities increased from 3% to 8%
(P = 0.015). The prevalence of birth mothers with a diagnosis of GDM increased from 1% to 8% (P < 0.001) over the 35-year period (Figure 1) , correlating with an overall increase in median maternal BMI, which increased from 21.5 to 23.9 (P < 0.001). Median age of mothers to infants with IH also increased throughout the study period from 27 years old at delivery to 29.5 years old at delivery (P < 0.001; Table 1 ).
| DISCUSSION
The incidence of IH is steadily increasing and positively correlates with decreasing gestational age and birthweight. 1, 6 Over the same time period, maternal age, maternal BMI, the use of ART, maternal progesterone and corticosteroid use, placental abnormalities, and GDM also increased in our cohort of mothers to infants with IH.
Artificial reproductive technology (ART) use increased over time, likely due to technology advances and increased availability of reproductive medicine in the same time period. Progesterone and corticosteroid use also increased throughout the study period. These factors are likely closely related, as progesterone may be given to maintain pregnancy in the setting of previous pregnancy loss, and corticosteroids may be given to accelerate fetal lung development in women at risk for premature birth. 10 Gestational diabetes mellitus (GDM) prevalence increased over the 35-year period, correlating with increasing incidence of IH over the same period. The increasing prevalence of GDM mirrors the GDM trend observed in the general U.S. population and may be partially attributable to the increase in median maternal BMI also observed over the 35-year period. 11, 12 Several of the known fetal complications in GDM are likely secondary to placental abnormalities; 13 it is of interest that the prevalence of placental abnormalities also increased over the study period. Increasing maternal BMI likely explains the increase in GDM, leading to the increase in placental abnormalities, and thus IH.
Increasing maternal age may be the underlying factor that links these prenatal risk factors. Median maternal age increased throughout the study period from 27 years old at delivery to 29.5 years old at delivery (P < 0.001). Increased maternal age was significantly associated with ART use, maternal progesterone use, maternal corticosteroid use, placental abnormalities, and GDM (Table 2 ). Maternal age also negatively correlated with gestational age (r = −0.11, P = 0.001) and positively correlated with BMI (r = 0.09, P = 0.009). The underlying causality of this association warrants further investigation.
Limitations of this study include that the population of Olmsted
County is predominantly a non-Hispanic white population, which may lead to population bias when reporting the occurrence of prenatal characteristics. The retrospective nature of this study may limit F I G U R E 1 Temporal trends of select prenatal risk factors between 1976 and 2010. Rate of assisted reproductive technologies increased from < 1% to 6% (P < 0.001) over the 35 years. The use of maternal progesterone increased from < 1% to 19% (P < 0.001). The percentage of birth mothers with a diagnosis of GDM increased from 1% to 8% (P < 0.001) over the 35-year period. Strengths of this study include the ability to utilize the REP to identify birth mother medical records of infants with IH and to examine the trends of prenatal risk factors over a 35-year period.
Thus, the recent increase in the incidence of infantile hemangiomas may be wholly or partially explained by a concomitant increase in placental abnormalities, as well as an increase in maternal age. Better understanding of the association and trends of these risk factors in the development of IH will direct further research in the pathogenesis of IH.
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